Congress·In Committee·H.R. 9077

To direct the Director of the National Institutes of Health and the Secretary of Health and Human Services to evaluate hormone variability and hormone testing, respectively, in women with respect to perimenopause.

1 day ago·View on Congress.gov

Legislative Progress

House

Senate

President

Law

Key Points

Full text not yet published

Congress hasn’t released the official text of this legislation yet. Once it’s published, this page will be updated with key points, impact assessments, and more.

Impact Analysis

Govbase has not yet run an impact analysis on this legislation.

Milestones

2 milestones2 actions

May 29, 2026House

Referred to the House Committee on Energy and Commerce.

May 29, 2026

Introduced in House

The bill was officially filed and given a number. It now enters the legislative queue.

Votes

No votes have been recorded for this legislation yet.

News

No related news coverage found for this legislation yet.

Source Information

Document Type

Congressional Bill

Bill NumberHR 9077

Congress119th Congress

ChamberHouse of Representatives

Latest ActionReferred to the House Committee on Energy and Commerce.

Data Sources

Congress.gov

Official legislative information

Sponsor

Analysis generated by AI. Always verify with official sources.